Literature DB >> 21890003

Short-term modulation of the exercise ventilatory response in younger and older women.

Helen E Wood1, Gordon S Mitchell, Tony G Babb.   

Abstract

The exercise ventilatory response (EVR; defined as the slope of the relationship between ventilation and CO(2) production) is reversibly augmented within a single exercise trial with increased respiratory dead space (DS) in both younger (Wood, H.E., Mitchell, G.S., Babb, T.G., 2008. Short-term modulation of the exercise ventilatory response in young men. J. Appl. Physiol. 104, 244-252) and older (Wood, H.E., Mitchell, G.S., Babb, T.G., 2010. Short-term modulation of the exercise ventilatory response in older men. Respir. Physiol. Neurobiol. 173, 37-46) men. The neural mechanism accounting for this augmentation is known as short-term modulation (STM) of the EVR. Since the effects of female sex hormones on STM are unknown, we examined the capacity for STM in healthy adult women of two age groups; nine younger (29±3 yrs, eumenorrheic) and seven older (69±3 yrs, postmenopausal) women were studied at rest and during cycle exercise (10 W, 30 W; not randomized) in control conditions and with added external DS (200 mL, 400 mL; randomized). Within groups, the main effects of DS and work rate on EVR were analyzed with a two-way repeated measures ANOVA; EVR comparisons between groups were made with unpaired t-tests. In both groups, EVR increased progressively with increasing DS volume (e.g. at 10 W 31±4 and 35±6 in control, 40±11 and 40±6 with 200 mL, 48±12 and 49±11 with 400 mL DS in younger and older women, respectively). In younger women, the effects of DS on EVR differed between work rates (significant interaction, p<0.05), although this was not the case for older women. In both groups, [Formula: see text] regulation was similar between DS and control; hence, increased EVR was not due to altered chemoreceptor feedback from rest to exercise. EVR with and without added DS did not differ between age groups. We conclude that the capacity for STM of the EVR with added DS is similar in healthy younger and older women.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21890003     DOI: 10.1016/j.resp.2011.08.011

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  7 in total

Review 1.  Mechanism of augmented exercise hyperpnea in chronic heart failure and dead space loading.

Authors:  Chi-Sang Poon; Chung Tin
Journal:  Respir Physiol Neurobiol       Date:  2012-12-27       Impact factor: 1.931

Review 2.  Submissive hypercapnia: Why COPD patients are more prone to CO2 retention than heart failure patients.

Authors:  Chi-Sang Poon; Chung Tin; Gang Song
Journal:  Respir Physiol Neurobiol       Date:  2015-04-17       Impact factor: 1.931

3.  Short-term modulation of the ventilatory response to exercise is preserved in obstructive sleep apnea.

Authors:  Vipa Bernhardt; Gordon S Mitchell; Won Y Lee; Tony G Babb
Journal:  Respir Physiol Neurobiol       Date:  2016-11-10       Impact factor: 1.931

Review 4.  Exercise ventilatory limitation: the role of expiratory flow limitation.

Authors:  Tony G Babb
Journal:  Exerc Sport Sci Rev       Date:  2013-01       Impact factor: 6.230

5.  Type III-IV muscle afferents are not required for steady-state exercise hyperpnea in healthy subjects and patients with COPD or heart failure.

Authors:  Chi-Sang Poon; Gang Song
Journal:  Respir Physiol Neurobiol       Date:  2015-04-21       Impact factor: 1.931

Review 6.  Obesity: challenges to ventilatory control during exercise--a brief review.

Authors:  Tony G Babb
Journal:  Respir Physiol Neurobiol       Date:  2013-05-21       Impact factor: 1.931

7.  External dead space explains sex-differences in the ventilatory response to submaximal exercise in children with and without obesity.

Authors:  Bryce N Balmain; Daniel P Wilhite; Dharini M Bhammar; Tony G Babb
Journal:  Respir Physiol Neurobiol       Date:  2020-06-05       Impact factor: 1.931

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.